A Phase II Clinical Trial of the Efficacy and Safety of Short-term (3 days) Enoxaparin for the Prevention of Venous Thromboembolism after Gastric Cancer Surgery

• Kuroda Shinji

• Kikuchi Satoru

• Nishizaki Masahiko

• Kagawa Shunsuke

• Hinotsu Shiro

• Fujiwara Toshiyoshi

抄録

Although intermittent pneumatic compression (IPC) has become common as perioperative prophylaxis for venous thromboembolism (VTE) consisting of pulmonary thromboembolism (PE) and deep vein thrombosis (DVT), the prophylactic effect against VTE, especially lethal PE, is not yet satisfactory. Therefore, pharmacologic prophylaxis, such as with enoxaparin, is desirable. While the efficacy and safety of enoxaparin have been proven in several clinical trials, concern about bleeding with longterm (at least 7 days) use have potentially decreased its widespread adoption. We have launched a phase II study to evaluate the efficacy and safety of short-term (3 days) enoxaparin, in which a total of 70 gastric cancer patients undergoing gastrectomy will be recruited, and the primary endpoint is the incidence of DVT. This study could contribute to making pharmacologic prophylaxis for VTE more common.

収録刊行物

• Acta Medica Okayama

  Acta Medica Okayama 70 (5), 401-404, 2016-10

  Okayama University Medical School

キーワード

• venous thromboembolism
• enoxaparin
• short-term use
• gastric cancer
• surgery

詳細情報

• CRID: 1390853649749467648
• NII論文ID: 120005859871
• NII書誌ID: AA00508441
• ISSN: 0386300X
• DOI: 10.18926/amo/54601
• PubMed: 27777435
• Web Site: https://ousar.lib.okayama-u.ac.jp/54601
• 本文言語コード: en
• データソース種別:
  • JaLC
  • IRDB
  • PubMed
  • CiNii Articles